Search Within

Andrew Jeffrey Dunbar

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (13)
  3. Research Letter (2)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Adult Leukemia (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. Executive Committee, Center for Hematologic Malignancies (35)
  5. GSK Faculty (35)
  6. Hematologic Malignancies, Division of (35)

More Groups

People
  1. Ross Levine (35)
  2. Sheng Cai (12)
  3. Young Park (12)
  4. Jacob Glass (8)
  5. Wenbin Xiao (8)
  6. Aaron Goldberg (7)

More People

Years
  1. 2024 (8)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (6)
  5. 2020 (6)
  6. 2019 (5)

More Years

Publications
  1. Blood (15)
  2. Haematologica (4)
  3. American Journal of Hematology (2)
  4. Blood Advances (2)
  5. Cell Reports (2)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Ferrata Storti Foundation (4)
  3. Cell Press (3)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo study (MYCEC0617) of CD34+-HSC and CEC mutational profile for investigating cell origin and pathogenesis of primary myelofibrosis (PMF)
    Meeting Abstract

    Farina, M.; Bernardi, S.; D'Adda, M.; Foroni, C.; Zanaglio, C.; Dunbar, A.; Re, F.; Cattina, F.; Rambaldi, B.; Zollner, T.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Overview of transgenic mouse models of myeloproliferative neoplasms (MPNs)
    Journal Article

    Dunbar, A.; Nazir, A.; Levine, R.
    Current Protocols in Pharmacology (2017)

    Fulltext@MSK | Save